Palliative Care and Hospice Access in the United States 2026
Palliative care has moved from a niche hospital service into a near-standard part of American healthcare over the past two decades, even as significant gaps in timing and access persist. Today, roughly 1.72 million Medicare beneficiaries receive hospice care each year, and 51.7% of all Medicare decedents used the hospice benefit before death, a share that has more than doubled since 2000, when fewer than a quarter of Medicare deaths involved hospice. Hospital-based palliative care has expanded just as dramatically, with 72% of hospitals with 50 or more beds now operating a dedicated palliative care team.
This report covers the full range of palliative care statistics shaping the US in 2026, from hospital team availability and penetration rates to hospice enrollment, the persistent problem of late referrals, where care actually happens, and the cost savings driving continued investment. Every figure below reflects the most current data available, drawn primarily from the Center to Advance Palliative Care (CAPC), the Centers for Medicare & Medicaid Services (CMS), and the National Hospice and Palliative Care Organization (NHPCO).
Interesting Facts About Palliative Care Statistics in US 2026
| Fact | Figure |
|---|---|
| Medicare beneficiaries receiving hospice care annually | around 1.72 million |
| Share of Medicare decedents who used hospice | 51.7% |
| Hospice use among Medicare deaths, 2000 | under 25% |
| Hospitals with 50+ beds with a palliative care team | 72% |
| Hospitals with 300+ beds with a palliative care team | 94% |
| Hospital palliative care penetration, 2008 vs 2019 | 2.5% → 5.6% |
| Median days remaining at hospice admission | 17 days |
| Hospice care days delivered at home | around 75% |
| Dementia’s share of hospice admissions | around 20%, now the top diagnosis |
| Cost reduction from early palliative consult | $3,237 per patient |
Source: CMS, NHPCO, Center to Advance Palliative Care
American palliative and hospice care has expanded on nearly every measurable dimension over the past two decades. 1.72 million Medicare beneficiaries now receive hospice care annually, and 51.7% of Medicare decedents used the benefit before death, more than double the share recorded in 2000. Hospital-based palliative care has grown in parallel: 72% of hospitals with 50 or more beds, and 94% of hospitals with 300 or more beds, now operate a dedicated palliative care team, and the share of hospital admissions receiving an initial palliative consult more than doubled between 2008 and 2019, from 2.5% to 5.6%.
Yet access and timing gaps remain deeply persistent. The median hospice patient is admitted with only 17 days left to live, despite the Medicare benefit covering up to six months of care, a gap researchers consistently trace to late physician referrals, family reluctance to accept what feels like “giving up,” and hospital discharge planners who often raise hospice only in a patient’s final 48 hours. Meanwhile, dementia has overtaken cancer as the single largest hospice diagnosis category, now accounting for roughly 20% of admissions, even as early palliative care consultation continues to demonstrate real financial value, cutting direct hospital costs by $3,237 per patient when delivered within three days of admission.
1. Hospital Palliative Care Team Availability in the US 2026
Share of Hospitals With a Palliative Care Team, by Size
50+ beds |███████████████████████████████████ 72%
300+ beds |█████████████████████████████████████ 94%
| Hospital Size | Share With a Palliative Care Team |
|---|---|
| 50+ beds | 72% |
| 300+ beds | 94% |
| All hospitals overall | over two-thirds |
| Mid-to-large hospitals | over 85% |
Source: Center to Advance Palliative Care, NASHP
Hospital-based palliative care has become the norm rather than the exception at any meaningfully sized American hospital. 72% of hospitals with 50 or more beds now operate a dedicated palliative care team, and that share climbs to 94% among hospitals with 300 or more beds, according to data compiled by the Center to Advance Palliative Care and cited by the National Academy for State Health Policy. Across all US hospitals of any size, over two-thirds report having a palliative care team, with the figure exceeding 85% among mid-to-large facilities specifically.
Despite this broad availability, coverage still varies considerably by hospital tax status, teaching designation, and geography, with rural and smaller community hospitals lagging well behind the large academic and urban centers driving the national averages upward. CAPC’s own 2024 Serious Illness Scorecard now rates every US state on its palliative care capacity specifically to highlight these persistent geographic gaps, part of a broader advocacy push that includes recommendations to revise Medicare Conditions of Participation for hospitals and skilled nursing facilities to formally require access to specialty palliative care teams meeting defined quality standards.
2. Palliative Care Penetration Rates in US Hospitals 2026
Hospital Admissions Receiving an Initial Palliative Consult
2008 |███████ 2.5% (1 in 40 admissions)
2019 |████████████████ 5.6% (1 in 18 admissions)
| Year | Penetration Rate | Equivalent |
|---|---|---|
| 2008 | 2.5% | 1 in 40 admissions |
| 2019 | 5.6% | 1 in 18 admissions |
| Pediatric programs, 2019 | 3.1% | Lower than adult average |
| Programs with all core disciplines staffed (adult) | 41% | — |
| Referrals from hospitalists | around 50% | More than 3x any other specialty |
Source: Center to Advance Palliative Care, National Palliative Care Registry
Penetration, the share of annual hospital admissions that receive an initial palliative care consult, more than doubled over an 11-year span tracked by CAPC’s National Palliative Care Registry. In 2008, inpatient programs provided consults to just 2.5% of admissions, roughly one in every 40 patients; by 2019, that figure had climbed to 5.6%, or one in every 18 patients, reflecting both growing physician awareness and expanding program capacity across the hundreds of hospitals reporting into the registry each year. Pediatric palliative programs consistently show lower penetration, averaging 3.1%, reflecting both the different disease patterns in pediatric populations and the field’s historically slower growth in children’s hospitals.
Staffing remains a genuine constraint on further growth. Only 41% of adult and 37% of pediatric programs reported having staff from every core discipline, physicians, advanced practice registered nurses, social workers, and chaplains, needed to deliver comprehensive palliative care. Referral patterns also skew heavily toward one source: hospitalists refer roughly half of all adult inpatient palliative care patients, more than three times the referral rate from any other single specialty, underscoring how central hospitalist training in communication and symptom management has become to expanding overall program reach.
3. Hospice Enrollment and Medicare Use in the US 2026
Share of Medicare Decedents Who Used Hospice
2000 |███████████ under 25%
2023 |███████████████████████████████ 51.7%
| Metric | Figure |
|---|---|
| Medicare beneficiaries receiving hospice care annually | ~1.72 million |
| Share of Medicare decedents using hospice, 2023 | 51.7% |
| Share of Medicare decedents using hospice, 2000 | under 25% |
| Adults at end of life covered under Medicare hospice benefit | 46% |
| Maximum hospice benefit coverage period | 6 months (with recertification) |
Source: CMS, NHPCO, MedPAC
Hospice has grown from a comparatively niche end-of-life option into mainstream American healthcare over the past quarter-century. According to the most recent complete data from the National Hospice and Palliative Care Organization, approximately 1.72 million Medicare beneficiaries received hospice care in the most recent full year tracked, and 51.7% of all Medicare decedents used the benefit before death, more than double the share recorded in 2000, when fewer than a quarter of Medicare deaths involved hospice care at all. A separate, broader estimate covering all adults at end of life, not just Medicare beneficiaries specifically, puts hospice coverage at 46%.
The Medicare hospice benefit itself covers up to six months of care, with extensions available when a physician recertifies that the patient’s prognosis remains terminal, and hospice costs are additionally covered by Medicaid and most private insurance plans, generally using Medicare’s own eligibility criteria as the template. Despite that generous coverage window, almost no families come anywhere close to using the full six months available to them, a gap explored in detail in the next section, which remains one of the most persistent and well-documented shortcomings in how American hospice care is actually delivered in practice.
4. The Late Referral Problem: Length of Hospice Stay in the US 2026
Median Days Remaining at Hospice Admission
Medicare benefit maximum |████████████████████████████████████████ up to 180 days
Actual median at admission |██ 17 days
| Referral Timing Metric | Figure |
|---|---|
| Median days remaining at hospice admission | 17 days |
| Maximum Medicare hospice benefit period | up to 180 days |
| Top reason cited: physician delay | Attending physician doesn’t raise hospice early enough |
| Second reason cited: family resistance | Hospice feels like “giving up” |
| Third reason cited: discharge timing | Hospital discharge planners often raise it in final 48 hours |
Source: NHPCO, CMS, peer-reviewed research
The gap between what the Medicare hospice benefit offers and what patients actually receive is stark. While the benefit covers up to six months of care, the median hospice patient is admitted with just 17 days remaining, according to NHPCO’s most recent complete data, meaning half of all hospice patients receive even less time than that median figure before death. Research consistently identifies the same three drivers behind this pattern: attending physicians frequently don’t raise hospice as an option early enough in a patient’s illness trajectory, families often resist a hospice referral because it can feel like accepting defeat or “giving up” on treatment, and hospital discharge planners in acute settings sometimes only mention hospice as an option during a patient’s final 48 hours in the hospital.
This late-referral pattern represents one of the central unresolved challenges in American end-of-life care, since earlier hospice enrollment is consistently associated with better symptom management, higher family satisfaction, and, in some clinical circumstances, even modestly longer survival compared with continued aggressive treatment. CAPC’s own policy recommendations directly target this gap, calling for expanded Medicare Alternative Payment Models that explicitly allow patients to receive palliative care concurrently with ongoing disease treatment, rather than forcing the binary choice between curative care and hospice enrollment that current eligibility rules can sometimes create in practice.
5. Where Hospice Care Happens in the US 2026
Share of Hospice Care Days by Setting
Home-based settings (private residence, assisted living, nursing home) |███████████████████████████████████ ~75%
Routine home care specifically |██████████████████████ ~52%
General inpatient (hospital/hospice unit) |█████ minority share
| Care Setting | Share of Hospice Care Days |
|---|---|
| Home-based settings overall | around 75% |
| Routine home care (patient’s own residence) | around 52% |
| General inpatient care (crisis management) | minority share |
| Americans who say they want to die at home | around 70% |
Source: NHPCO, CMS
Most American hospice care happens far from a hospital bed. Roughly 75% of all hospice care days occur in home-based settings, whether a private residence, an assisted-living community, or a nursing home, with routine home care in a patient’s own residence accounting for about 52% of all patient-days on its own. General inpatient hospice care, delivered in a hospital or dedicated hospice inpatient unit, makes up a comparatively small minority share, reserved specifically for symptom crises that cannot be safely managed in a home or residential setting.
This distribution aligns closely with stated patient preferences: roughly 70% of Americans say, when asked, that they would prefer to die at home rather than in an institutional setting. Patients frequently move between these different care settings as their condition evolves over the course of a hospice enrollment, starting in routine home care and shifting temporarily to general inpatient status during an acute symptom crisis before returning home once stabilized, a flexibility built directly into how the Medicare hospice benefit structures its different levels of care and corresponding daily payment rates.
6. Dementia and the Changing Face of Hospice Diagnoses in the US 2026
Leading Hospice Diagnosis Categories
Dementia (current) |████████████████████ ~20%, now #1
Cancer (historical peak, 1990s) |████████████████████████ dominant through the 1990s
| Metric | Figure |
|---|---|
| Dementia’s current share of hospice admissions | around 20%, largest single category |
| Average age at hospice admission | around 80 years |
| Largest single age bracket at admission | 85 and older |
| Historical dominant diagnosis (through the 1990s) | Cancer |
Source: NHPCO, CMS
The clinical face of American hospice care has fundamentally shifted over the past three decades. Cancer was the dominant hospice diagnosis through the 1990s, and the Medicare hospice benefit itself was originally designed with cancer’s typically more predictable decline in mind. Today, Alzheimer’s disease and other forms of dementia have overtaken cancer to become the single largest diagnosis category among hospice admissions, now accounting for roughly 20% of all patients enrolling in hospice care nationally.
That shift has pushed the average hospice patient considerably older: the average age at admission now sits around 80 years, and the single largest age bracket among all hospice admissions is 85 and older, making American hospice care today overwhelmingly a form of geriatric care. This dementia-driven shift creates genuine eligibility complications too, since the Medicare hospice benefit’s prognosis-based eligibility standard, requiring a life expectancy of six months or less if the underlying disease runs its normal, expected course, is considerably harder to apply confidently to dementia’s typically slow, unpredictable decline than it is to cancer’s more clearly staged prognosis, a mismatch researchers say contributes directly to the late-referral pattern documented earlier in this article.
7. Consolidation and For-Profit Hospice Growth in the US 2026
Hospice Market Consolidation
10 largest hospice chains |███████████████████████████████████ ~1/3 of all US hospice patients
Remaining thousands of providers |██████████████████████████████████████████████████████████████ ~2/3 of patients
| Consolidation Metric | Figure |
|---|---|
| Share of US hospice patients treated by the 10 largest chains | roughly one-third |
| For-profit hospice spending pattern | Less per patient-day on nursing/physician visits |
| For-profit enrollment pattern | Higher share of long-stay dementia patients |
| CMS Hospice Special Focus Program launched | 2024 |
| Worst-performing providers targeted for monitoring | bottom 1% |
Source: NHPCO, MedPAC, CMS
The hospice industry has consolidated significantly in recent years, driven by a wave of private-equity acquisitions that has concentrated an outsized share of the market in a small number of large operators. The ten largest hospice chains in the US now treat roughly one-third of all hospice patients nationally, and research consistently finds meaningful quality and spending differences tied to this consolidation trend: for-profit hospices tend to spend less per patient-day on nursing and physician visits than nonprofit providers, while enrolling a higher share of long-stay dementia patients, the population where the Medicare program’s flat daily payment rate tends to be most profitable given typically lower per-visit clinical intensity.
CMS has responded directly to these consolidation-driven quality concerns by launching a Hospice Special Focus Program in 2024, which identifies and intensively monitors the worst-performing 1% of hospice providers nationally. Family experience is tracked separately and rigorously through the CMS CAHPS Hospice Survey, a standardized federal questionnaire mailed to a sample of family caregivers between two and twelve months after a patient’s death, and the resulting satisfaction numbers remain notably strong even amid the sector’s consolidation trend, with 81% of surveyed caregivers rating their hospice experience a 9 or 10 out of 10. Separately, Medicare Advantage plans, whose own enrollment and benefit trends continue reshaping much of American healthcare financing, now have the option to cover hospice benefits directly under specific transition guardrails designed to smooth the shift for beneficiaries during their first two years under the arrangement.
8. Cost Savings and the Economic Case for Palliative Care in the US 2026
Documented Cost Savings From Early Palliative Care
Per-patient hospital cost reduction (consult within 3 days) |████████████████████████████████████ $3,237
Sutter Health advanced illness management program savings |████████████████████████████████████████████ $8,000-$9,000/patient/year
| Cost Savings Metric | Figure |
|---|---|
| Direct hospital cost reduction, palliative consult within 3 days | $3,237 per patient |
| Basis for the finding | Meta-analysis of 133,000+ cases |
| Sutter Health advanced illness management savings | $8,000–$9,000 per patient per year |
| Federal quality measure development funding (2018) | $5.5 million |
Source: Center to Advance Palliative Care, CMS
The economic case for expanding palliative care access has grown increasingly well-documented. A 2018 meta-analysis of more than 133,000 hospital cases, cited extensively by CAPC in its hospital financial planning tools, found that palliative care consultations conducted within three days of hospital admission were associated with a $3,237 reduction in direct hospital costs per patient, measured in 2015 inflation-adjusted dollars, figures that reflect reduced use of unnecessary interventions and shorter overall hospital stays once symptom management and care goals are clarified early. Integrated health systems have documented even larger returns at the population level: Sutter Health’s advanced illness management program has demonstrated savings of $8,000 to $9,000 per patient per year among enrolled patients.
Federal policymakers have taken note of this evidence base, with CMS awarding $5.5 million in 2018 to the American Academy of Hospice and Palliative Medicine, supported by the RAND Corporation, specifically to develop new quality measures around communication and symptom management skills within palliative care. For a fuller picture of what hospice-specific care costs and how it’s financed across Medicare, Medicaid, and private insurance, hospice care statistics provide additional detail on the financial side of end-of-life care that complements the hospital-based palliative care economics detailed throughout this article, together making a increasingly difficult-to-ignore case for earlier and broader palliative care integration across the entire US healthcare system.
Disclaimer: The data research report we present here is based on information found from various sources. We are not liable for any financial loss, errors, or damages of any kind that may result from the use of the information herein. We acknowledge that though we try to report accurately, we cannot verify the absolute facts of everything that has been represented.
